Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Cochrane

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Respiratory Medicine|September 1, 1996
Psychosocial factors and asthmaC M Bosley, Z M Corden, G M Cochrane
Respiratory Medicine|January 1, 1990
Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective studyC R Horn, T J Clark, G M Cochrane
Scandinavian Journal of Respiratory Diseases|January 1, 1976
Asbestos exposure and small airways disease [proceedings]R Rodriguez-Roisin, G M Cochrane, T J Clark
The American Review of Respiratory Disease|February 1, 1975
Clinical relevance of the flow rate response to low density gas breathing in asthmaticsS R Benatar, T J Clark, G M Cochrane
Lancet (London, England)|October 1, 1983
Terbutaline "ghost" tabletsD R Fish, G M Cochrane, E J Essex
The European Respiratory Journal|March 1, 1994
Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance?C M Bosley, D T Parry, G M Cochrane
Respiratory Medicine|January 1, 1989
Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma?C R Horn, E Essex, P Hill, et al.
Australian and New Zealand Journal of Medicine|June 1, 1990
Plasma concentrations of salbutamol in acute severe asthmaticsL D Lewis, M McLaren, E Essex, et al.
British Journal of Clinical Pharmacology|June 1, 1988
Is posture clinically important when monitoring theophylline therapy?C R Horn, F Stirling, G M Cochrane, et al.
Guy'S Hospital Reports|January 1, 1973
The effect of benzoctamine on the ventilatory response to carbon dioxide in normal subjects and in patients with chronic airways obstructionG M Cochrane, T J Clark, J V Collins, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Respiratory Medicine|September 1, 1996
Psychosocial factors and asthmaC M Bosley, Z M Corden, G M Cochrane
Respiratory Medicine|January 1, 1990
Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective studyC R Horn, T J Clark, G M Cochrane
Scandinavian Journal of Respiratory Diseases|January 1, 1976
Asbestos exposure and small airways disease [proceedings]R Rodriguez-Roisin, G M Cochrane, T J Clark
The American Review of Respiratory Disease|February 1, 1975
Clinical relevance of the flow rate response to low density gas breathing in asthmaticsS R Benatar, T J Clark, G M Cochrane
Lancet (London, England)|October 1, 1983
Terbutaline "ghost" tabletsD R Fish, G M Cochrane, E J Essex
The European Respiratory Journal|March 1, 1994
Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance?C M Bosley, D T Parry, G M Cochrane
Respiratory Medicine|January 1, 1989
Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma?C R Horn, E Essex, P Hill, et al.
Australian and New Zealand Journal of Medicine|June 1, 1990
Plasma concentrations of salbutamol in acute severe asthmaticsL D Lewis, M McLaren, E Essex, et al.
British Journal of Clinical Pharmacology|June 1, 1988
Is posture clinically important when monitoring theophylline therapy?C R Horn, F Stirling, G M Cochrane, et al.
Guy'S Hospital Reports|January 1, 1973
The effect of benzoctamine on the ventilatory response to carbon dioxide in normal subjects and in patients with chronic airways obstructionG M Cochrane, T J Clark, J V Collins, et al.
Pageof 13